Shenzhen Hornetcorn Bio-technology Company
CompanyChina
Shenzhen Hornetcorn Bio-technology Company develops one asset, in phase 2 (human umbilical cord mesenchymal stem cells in decompensated liver cirrhosis). Mostly cell therapy; based in China.
- 1
- Asset
- Furthest stage
- Phase 2
- 8
- Trials
- 3
- Signals
Pipeline
1human umbilical cord mesenchymal stem cells
Allogeneic umbilical cord-derived mesenchymal stem cells for retinal tissue support and regeneration
Phase 2, Cell therapy, decompensated liver cirrhosis, acute ischemic stroke (Phase 1)
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials8
- Signals10
- Similar companies6